SCHEMBL8060816

SCHEMBL8060816

CC1CC(C(O)(C(=O)O)c2ccccc2)CC(C)(C)C1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.53
NFE2L2 Q16236 1/20 0.53
LMNA P02545 2/20 0.43
NR1I2 O75469 1/20 0.43
ABCB11 O95342 1/20 0.43
ALDH1A1 P00352 3/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
CYP3A4 P08684 2/20 0.42
CYP1A2 P05177 1/20 0.42
CHRM3 P20309 8/20 0.38
CHRM2 P08172 5/20 0.38
CHRM1 P11229 5/20 0.38
IDH1 O75874 1/20 0.36
CCR2 P41597 2/20 0.36
HTT P42858 1/20 0.35
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29986278 0.77 KEAP1 (0.49) KEAP1NFE2L2LMNAALDH1A1CYP2C9
SCHEMBL4523677 0.72 KEAP1 (0.54) KEAP1NFE2L2CHRM3CHRM2CHRM1
SCHEMBL4518810 0.72 KEAP1 (0.54) KEAP1NFE2L2CHRM3CHRM2CHRM1
SCHEMBL2764040 0.72 KEAP1 (0.85) KEAP1NFE2L2LMNAALDH1A1CYP3A4
SCHEMBL6639537 0.72 KEAP1 (0.62) KEAP1NFE2L2CHRM3CHRM2CHRM1
SCHEMBL27503465 0.72 KEAP1 (0.62) KEAP1NFE2L2CHRM3CHRM2CHRM1
SCHEMBL3825105 0.72 APLNR (0.38) LMNANR1I2ABCB11ALDH1A1CYP2C9
SCHEMBL3825110 0.72 APLNR (0.38) LMNANR1I2ABCB11ALDH1A1CYP2C9
Hydrochloric Acid SCHEMBL4560459 0.71 KEAP1 (0.53) KEAP1NFE2L2CHRM3CHRM2CHRM1
SCHEMBL2763565 0.70 KEAP1 (0.93) KEAP1NFE2L2ALDH1A1CYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6057359-A NEW ESTERS OF BACCATIN-III, 10-DEACETYLBACCATIN-III AND 14-OH-10-DEACETYLBACCATIN-III USED FOR THE TREATMENT OF ECZEMA, PSORIASIS AND METABOLIC DISORDERS MARIGEN S.A. (CH) 2000-05-02 US disclosed
EP-0868422-A1 ULTRAMICROEMULSION OF SPONTANEOUSLY DISPERSIBLE CONCENTRATES OF ESTERS OF BACCATIN-III COMPOUNDS WITH ANTITUMOR AND ANTIVIRAL EFFECT MARIGEN S.A. (CH) 1998-10-07 EP disclosed
EP-0858331-A1 SPONTANEOUSLY DISPERSIBLE CONCENTRATES OF STEROL ESTERS AND VITAMIN D DERIVATIVES WITH ANTIVIRAL, VIRUCIDAL AND/OR PARASITICIDAL EFFECT MARIGEN S.A. (CH) 1998-08-19 EP disclosed
WO-1998013359-A1 ULTRAMICROEMULSION OF SPONTANEOUSLY DISPERSIBLE CONCENTRATES OF ESTERS OF BACCATIN-III COMPOUNDS WITH ANTITUMOR AND ANTIVIRAL EFFECT MARIGEN S.A. (CH) 1998-04-02 WO disclosed
WO-1998006390-A1 SPONTANEOUSLY DISPERSIBLE CONCENTRATES OF STEROL ESTERS AND VITAMIN D DERIVATIVES WITH ANTIVIRAL, VIRUCIDAL AND/OR PARASITICIDAL EFFECT MARIGEN S.A. (CH) 1998-02-19 WO disclosed
US-5593691-A DIESTERS AND UNSATURATED DIESTERS WITH COSMETICS, DRUGS AND TENSIDES MARIGEN S.A. (CH) 1997-01-14 US disclosed
EP-0157151-B1 NEW PROCESS FOR PREPARING CIS-3,3,5-TRIMETHYLCYCLOHEXYL-D,L-ALPHA-(3-PYRIDINECARBOXY)-PHENYLACETATE RAVIZZA S.p.A. (IT) 1988-07-13 EP disclosed
EP-0157151-A1 New process for preparing cis-3,3,5-trimethylcyclohexyl-D,L-alpha-(3-pyridinecarboxy)-phenylacetate RAVIZZA S.p.A. (IT) 1985-10-09 EP disclosed